KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Inventory (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Change in Inventory data on record, last reported at -$11.0 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 121.48% year-over-year to -$11.0 million; the TTM value through Dec 2025 reached -$50.7 million, down 119.8%, while the annual FY2025 figure was -$50.7 million, 119.8% down from the prior year.
  • Change in Inventory reached -$11.0 million in Q4 2025 per EW's latest filing, down from $1.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $99.3 million in Q4 2023 and bottomed at -$41.6 million in Q2 2025.
  • Average Change in Inventory over 5 years is $34.4 million, with a median of $37.0 million recorded in 2024.
  • Peak YoY movement for Change in Inventory: soared 1060.0% in 2022, then plummeted 144.16% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $6.6 million in 2021, then surged by 843.94% to $62.3 million in 2022, then soared by 59.39% to $99.3 million in 2023, then plummeted by 48.44% to $51.2 million in 2024, then tumbled by 121.48% to -$11.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$11.0 million in Q4 2025, $1.8 million in Q3 2025, and -$41.6 million in Q2 2025.